GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.
about
Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus.A technological update of molecular diagnostics for infectious diseasesHigher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysisHuman papillomavirus 45 genetic variation and cervical cancer risk worldwideClinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) studyTriaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.Mining for viral fragments in methylation enriched sequencing data.Human Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data.DNA microarray format for detection and subtyping of human papillomavirus.HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing countryHigh level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas.hTERT promoter activity and CpG methylation in HPV-induced carcinogenesisAbundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assayPrevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control studyComparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East CongoHuman papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).Risk of HIV acquisition among circumcised and uncircumcised young men with penile human papillomavirus infection.Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection.Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan.Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPVComparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimensMethylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomavirusesHPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAPSimultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assayReverse line blot assay for direct identification of seven Streptococcus agalactiae major surface protein antigen genesHIV and other sexually transmitted infections among men who have sex with men recruited by RDS in Buenos Aires, Argentina: high HIV and HPV infection.Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA.Bead-based multiplex genotyping of human papillomaviruses.Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme.Global proficiency study of human papillomavirus genotyping.Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.Use of PCR and reverse line blot hybridization assay for rapid simultaneous detection and serovar identification of Chlamydia trachomatis.Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign.
P2860
Q24811477-F5C2CC19-5188-40B3-9E93-DF1B4EF88638Q27487056-65B5CD3A-6D03-44F2-B139-F456BA13E476Q28386178-B3BCF352-078E-440B-80E1-8F6F904FC8F9Q28659720-1B4558D2-3171-4CCD-8A7B-33766DD6514BQ30651813-CAD3581F-9448-444D-B2CA-066098CC12F3Q30863996-586B03C3-6B56-46C6-B3BE-3F14CA1CD4EFQ30896273-9C4E2FD3-3B62-4D2F-8788-2FCE048C69E5Q31012345-8DC4C3FE-F8C8-4D4E-9364-17162A055C10Q31058927-C86A2146-8278-48F6-BBA7-302058B1DA4FQ33568522-C9955B9C-4E38-496F-9C41-5E13B8112DDBQ33597525-AB94DB56-780E-404B-AADC-2288C1B299F9Q33599338-7BC161EB-1258-43AE-8C80-A23171CDD287Q33614132-8A73A38B-AC50-48AC-A622-42DFB8913D7DQ33636859-F77254CF-B585-494B-8851-E38404A01AB5Q33688320-78CECE7E-B11C-4A0A-B1FF-DA5391EE33B0Q33704719-166B32DC-36C3-43B9-B153-A9610F8B61CAQ33747434-76D4DB34-4767-47A5-AB1A-2D5628035AC0Q33778119-4DDBBA3A-DC26-4024-B105-736FD98893C4Q33817963-A6DE0228-8DDA-46A5-9B6F-EA48ED5008B6Q33865960-07B18E67-2A76-44C1-B744-5C6FB24F9D77Q33903739-88B7A5AC-6880-4EAE-AA98-50D90436EA73Q33963857-190E8270-F7B0-45BD-BBFE-8BD816BE23D7Q34042389-DEF8BA43-5588-4998-B6EA-0A1AC8D43BD3Q34049709-2C359CC5-8F41-45E0-A730-1F28A5F5B74EQ34102195-178359C1-F844-4D1D-A094-4CB0690D7B0EQ34138292-9D4B96F5-7FB5-43CF-9130-92842F591B69Q34162496-35C65121-B512-4FFD-A854-95850DADB553Q34239718-380A5AA5-5882-4435-BB5D-1A8BB34704F0Q34301604-018055E9-C682-43C3-9DAF-486FAF8F305CQ34325853-6E311C00-2652-4DEA-9B6C-68E02D808A29Q34328319-90194FF0-6D62-4768-9F76-0C9074CED520Q34400805-D311D1D1-D0E0-4CB7-BE3C-A7FE0E71AA77Q34430779-3BEDFB12-2F8C-4364-876E-C27FEEA80233Q34430808-2B922398-23DC-4CC8-BDE6-233F9D4E6603Q34469136-84FAC308-1F2C-437B-9124-1C2363586B1BQ34489632-FF949C07-290F-41E7-A1B2-AF976276D83DQ34522328-B7FB9E20-02B2-4612-B2B3-072959EAAB70Q34569181-AD4C6B4E-7E2E-4F6F-95A9-60C426B723BDQ34569248-FFE258FC-1159-447E-811F-461F3886BA8BQ34572303-777E19AA-6607-4299-A481-1B36D6AF1F96
P2860
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
GP5+/6+ PCR followed by revers ...... uman papillomavirus genotypes.
@ast
GP5+/6+ PCR followed by revers ...... uman papillomavirus genotypes.
@en
type
label
GP5+/6+ PCR followed by revers ...... uman papillomavirus genotypes.
@ast
GP5+/6+ PCR followed by revers ...... uman papillomavirus genotypes.
@en
prefLabel
GP5+/6+ PCR followed by revers ...... uman papillomavirus genotypes.
@ast
GP5+/6+ PCR followed by revers ...... uman papillomavirus genotypes.
@en
P2093
P2860
P1476
GP5+/6+ PCR followed by revers ...... uman papillomavirus genotypes.
@en
P2093
Adriaan J C van den Brule
Chris J L M Meijer
Leo M Schouls
Nathalie Fransen-Daalmeijer
Peter J F Snijders
P2860
P304
P356
10.1128/JCM.40.3.779-787.2002
P407
P577
2002-03-01T00:00:00Z